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Background: We studied the effect of carbon black (CB) agglomerated nanomaterial on biological membranes as
revealed by shapes of human erythrocytes, platelets and giant phospholipid vesicles. Diluted human blood was
incubated with CB nanomaterial and observed by different microscopic techniques. Giant unilamellar phospholipid
vesicles (GUVs) created by electroformation were incubated with CB nanomaterial and observed by optical microscopy.
Populations of erythrocytes and GUVs were analyzed: the effect of CB nanomaterial was assessed by the average
number and distribution of erythrocyte shape types (discocytes, echinocytes, stomatocytes) and of vesicles in test
suspensions, with respect to control suspensions. Ensembles of representative images were created and analyzed using
computer aided image processing and statistical methods. In a population study, blood of 14 healthy human donors
was incubated with CB nanomaterial. Blood cell parameters (concentration of different cell types, their volumes and
distributions) were assessed.
Results: We found that CB nanomaterial formed micrometer-sized agglomerates in citrated and phosphate buffered
saline, in diluted blood and in blood plasma. These agglomerates interacted with erythrocyte membranes but did not
affect erythrocyte shape locally or globally. CB nanomaterial agglomerates were found to mediate attractive interaction
between blood cells and to present seeds for formation of agglomerate - blood cells complexes. Distortion of disc shape
of resting platelets due to incubation with CB nanomaterial was not observed. CB nanomaterial induced bursting of GUVs
while the shape of the remaining vesicles was on the average more elongated than in control suspension, indicating
indirect osmotic effects of CB nanomaterial.
Conclusions: CB nanomaterial interacts with membranes of blood cells but does not have a direct effect on local or
global membrane shape in physiological in vitro conditions. Blood cells and GUVs are convenient and ethically acceptable
methods for the study of effects of various substances on biological membranes and therefrom derived effects on
organisms.
Keywords: Carbon black nanomaterial, Carbon black, Air pollution, Nanotoxicity, Cell membranes, Phospholipid bilayer,
Model systems, Blood cells* Correspondence: veronika.kralj-iglic@fe.uni-lj.si
1Laboratory of Clinical Biophysics, University of Ljubljana, Faculty of Health
Sciences, Zdravstvena pot 5, Ljubljana SI-1000, Slovenia
Full list of author information is available at the end of the article
© 2015 Pajnič et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Pajnič et al. Journal of Nanobiotechnology  (2015) 13:28 Page 2 of 17Background
Recent advances in development and industrial produc-
tion of nanomaterials require assessment of their effects
on human and animal health. Toxicity of nanomaterials
has therefore become an issue regarding the question
which methods are the most appropriate for determining
health risk [1,2]. Nanomaterial introduces also effects
that cannot be explained by composition of the material
and chemical reactions, but require consideration of
non-specific properties, such as size and shape of parti-
cles, their electromagnetic properties and interactions
with biological material [3]. Since the underlying mecha-
nisms are largely unknown, standard methods for re-
search, testing and safety are not necessarily relevant for
these materials. Standard methods for research and test-
ing of various compounds include experiments on ex-
perimental animals. These methods were found to have
poor predictability regarding other species, in particular
human, as shown by carcinogeneity studies [4-6]. It was
suggested that in vitro research may provide essential in-
formation pertaining to the human health risks posed by
nanoparticle exposure [7]. With fast and extensive devel-
opment of new nanomaterials and their use in medicine
and industry there is urgent need to develop effective
and low cost methods that will enable understanding
basic processes in living organisms. The role of nonspe-
cific biophysical mechanisms has hitherto been underes-
timated as potentially essential in revealing biological
processes but should be considered in future paradigms
of research and testing of nanomaterials.
Exogenously added substances first come in contact
with cells by interacting with the membrane, so it is of
great interest to study the interaction of these substances
with biological membranes. Convenient systems for such
studies are mammalian erythrocytes and giant unilame-
lar phospholipid vesicles (GUVs) composed of a closed
bilayer membrane. These entities do not have internal
structure (other than cortical membrane skeleton in case
of erythrocytes) so their equilibrium shape is determined
by the minimum of the membrane free energy [8]. Inter-
action of the added substance with the membrane causes
changes in the membrane properties and in the con-
straints imposed upon the cell/vesicle (fixed area of the
membrane, fixed difference between the areas of the two
membrane layers, fixed cell/vesicle volume) which is
reflected in the shape change [9]. Since mammalian
erythrocytes and phospholipid vesicles (sized up to 100
micrometers) can be observed under the optical micro-
scope, the effect of the exogenously added substances
can be directly followed in real time.
Further, of special interest are processes caused by ex-
ogenously added substances that increase the risk for
thromboembolic events [10]. Some parameters of these
processes, e.g. activation of platelets and coalescence ofmembranous structures due to the presence of nanoma-
terial have previously been studied [11].
Membrane – nanomaterial interactions could be consid-
ered as one of the basic elements in an effective strategy of
research and testing. These interactions are subject to bio-
physical methods which provide theoretical background.
The accompanying experiments on the microscopic level
are performed in vitro, on the artificial membranes and cell
membranes.
Carbon black (CB) is a material produced by the in-
complete combustion of carbon. Commercially available
CB is a well characterized carbonaceous core particle
that has been used extensively as a model for Diesel ex-
haust particles, which showed proinflamatory and pro-
thrombotic systemic effects [12]. CB nanoparticles that
are produced in traffic are present in the air, so living
beings are commonly exposed to them. CB nanoparticles
thus enter the body by means of inhalation. As they are
very small, they cross biological barriers, enter the circu-
lation and are spread in tissues and fetal organs. In the
body, they affect the cell function and due to intercellu-
lar interactions [13] affect the entire organism. CB nano-
material was found to have a size-dependent effect on
in vitro cultures [14]. The reported effects of CB on ani-
mals include changes in development, in the immune re-
sponse, and in gene expression [15]. Epidemiological
studies on human have shown that CB nanomaterial is
connected with adverse effects on health [16], in particu-
lar, with respiratory diseases and lung cancer.
In this work we studied the effect of CB nanomaterial
on biological membranes as revealed by shape changes
of erythrocytes and GUVs. These model systems and
their interactions with the added substances have previ-
ously been used in the study of the effects of various
compounds [17-21] including nanoparticles [11,22-26]
on cells and their membranes and were found to
contribute to better understanding of the relevant
mechanisms which are common in ex vivo and in vivo
exposures.
Results
Characterization and imaging of carbon black nanomaterial
suspensions
Transmission and scanning electron microscope (TEM
and SEM, respectively) images of CB nanomaterial sus-
pended in citrated and phosphate-buffered saline (PBS)
showed agglomerates of globular nanoparticles of homo-
geneous size about 20 nm (Figure 1A and B, respectively)
and a small amount of larger aggregates (Figure 1C). By
using the optical microscope, we could inspect relatively
large volume of the test sample. We observed even larger
aggregates in PBS (Figure 1D1) and in platelet rich
plasma (Figure 1D2). These large aggregates had different
sizes, some of them extending over 10 μm (Figure 1D).
Figure 1 Micrographs of agglomerated carbon black nanomaterial suspended in citrated and phosphate–buffered saline. Agglomerated
carbon black (CB) nanomaterial suspended in citrated and phosphate buffered saline (PBS) as observed by transmission electron microscope
(TEM) (A) and scanning electron microscope (SEM) (B). The primary particles are amorphous with homogeneous size about 20 nm. A small
number of larger agglomerates were found in PBS, as observed by TEM (C) and by the optical microscope (D1), and in platelet rich plasma (D2).
Black arrows point to agglomerates, white arrow points to an erythrocyte and gray arrow points to a platelet.
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previously sonicated CB nanomaterial showed a wide
distribution of the agglomerates with respect to size
(ranging from 500 to 2500 nm). Zeta potential of the PBS
suspension of CB nanomaterial at pH = 7.32 was -29 mV.
We could not perform DLS measurements of CB
nanomaterial suspensions in 0.3 M glucose solution due
to strong agglomeration and fast sedimentation of CB
nanomaterial.
Carbon black nanomaterial interactions and effects on
erythrocyte shape
Figure 2 shows the effect of CB nanomaterial on the shape
of washed human erythrocytes as observed by SEM.
Panels A, D and G show the control samples (with added
PBS) and panels B, E and H show the samples with added
PBS-suspended CB nanomaterial after 1, 3 and 24 hours
of incubation, respectively. For comparison, panels C, F
and I show another control with added PBS-suspended
zinc oxide nanoparticles (ZnO) [11]. Normal discocytic
shapes of erythrocytes were observed after 1, 3 and
24 hours in all samples. Singular echinocytes were found
in a positive control (ZnO-treated) samples ([11],
Figure 2C, F and I). It can be seen in panels B, E and H
that agglomerated CB nanomaterial adhered to the
erythrocyte membrane. Large CB nanomaterial agglomer-
ates have filled the discocyte dimple (Figure 2B, black
arrow) but also agglomerates adhered to the membrane at
any location on the erythrocyte surface (Figure 2E and H,
black arrows). Large CB nanomaterial agglomerates canadhere to two cells and therefore mediate the interaction
between them (Figure 2B, white arrow). A close-up view
shows that in the case of small contact area between CB
agglomerate and membrane (Figure 3A, C and D, white
arrows), the CB nanomaterial does not affect the local
membrane curvature (the membrane shape is undisturbed
at the site of contact of the CB nanomaterial agglomerate).
Moreover, the global shape of the cell remains discocytic
(Figure 3A). However, singular disintegrated cells were
found in the sample (Figure 3B). The cell shown in
Figure 3B adhered to huge CB nanomaterial agglomerate
and the shape was distorted. Large pores in the membrane
(Figure 3B, white arrow) caused the exchange of the inner
and the outer cell solutions. A similar process of cell
deformation upon the adhesion to a huge agglomerate is
indicated in Figure 2H (white arrow), but in this case, the
membrane integrity is still preserved.
Carbon black effects on erythrocyte shape in population
of erythrocytes and platelets
Figure 4 shows the effect of CB nanomaterial on coales-
cence of washed erythrocytes in three subjects with no rec-
ord of the disease (A, B and C) as observed by the phase
contrast optical microscope. Washed erythrocytes were in-
cubated with PBS for control and with CB nanomaterial
(suspended in PBS) for 1, 3 and 24 hours, respectively. It
can be seen that the control samples remained unchanged
after 1, 3 and 24 hours while in the test samples, the eryth-
rocytes have gathered around larger CB nanomaterial ag-
glomerates already after 1 hour. The size of the complexes
Figure 3 Adhesion of large agglomerates of carbon black nanomaterial to the erythrocyte membrane. In the case of a rather small
contact area (panels A, C and D, white arrows) the local and the global membrane shape remained undisturbed. In the case of a large contact
area (B) the membrane was considerably affected leading to formation of a ghost with large pores in the membrane (B, white arrow).
Figure 2 The effect of carbon black nanomaterial on washed human erythrocytes. The effect of carbon black (CB) nanomaterial on washed
human erythrocytes as observed by scanning electron microscope. Panels A, D and G show the control samples with added citrated and phosphate
buffered saline (PBS); panels B, E and H show the samples with added PBS-suspended CB nanomaterial after 1 hour, 3 hours and 24 hours of
incubation, respectively and panels C, F and I show the samples with added PBS-suspended ZnO after 1 hour, 3 hours and 24 hours, respectively. Large
CB agglomerates adhered to the erythrocyte surface (B, E, H, black arrows). Agglomerate which adhered to two erythrocytes mediated a bridging
interaction between them (B, white arrow). In ZnO-treated samples, singular echinocytes were found (C, F, I, white triangles).
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Figure 4 The effect of carbon black nanomaterial on coalescence between erythrocytes. The effect of carbon black (CB) nanomaterial on
coalescence between erythrocytes in three subjects with no record of the disease (marked A, B and C) as observed by the phase contrast optical
microscope. Washed erythrocytes were incubated with citrated and phosphate buffered saline (PBS) for control (denoted by C) and with
PBS-suspended CB nanomaterial (denoted by CB) for 1, 3 and 24 hours, respectively, as indicated.
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(Figure 4). Erythrocytes that were not in direct contact
with the visible CB nanomaterial agglomerates did not ad-
here to each other.
We analyzed the effect of CB nanomaterial on erythro-
cyte shape at the population level (Table 1). The examined
blood initially contained mostly discocytes (Table 1). With
time the portion of discocytes in the test sample and in
the control sample decreased at the expense of the portion
of echinocytes (Table 1), but the effect was stronger in the
control sample. The differences between the respective
test and control samples were statistically significant (p <
0.05) (Table 1). We observed no decreasing trend of the
number of erythrocytes in the samples with time.Figure 5 shows the effect of CB nanomaterial on popula-
tion of platelets as observed by SEM. Washed platelets
were incubated with PBS (control; A, D, G) and with CB
nanomaterial suspended in PBS (B, E, H) for 1, 3 and
24 hours, respectively. For comparison, we show also
platelets incubated with a positive control (ZnO agglomer-
ated nanomaterial [11]) for 1, 3 and 24 hours, (C, F, I, re-
spectively). After 1 and 3 hours, the control and test
samples showed disc-like shapes (A, B, D, E) characteristic
for resting platelets. There were some platelets exhibiting
protrusions and shape deformation characteristic for acti-
vated platelets after 24 hours in the control and in the test
sample (G,H). For comparison, the effect of ZnO nanopar-
ticles caused shape transformation in some platelets after
Table 1 A population study of the effect of carbon black nanomaterial on erythrocyte shape
Sample size
(number of frames)
Test Control Difference between test and control
















1 hour 56/54 99 (2) 1 (1) 0 90 (8) 9 (7) 1 (5) 9 (<10-6, 1) -8 (<10-6, 1) NA
3 hours 50/53 90 (18) 9 (18) 0 84 (11) 16 (11) 0 6 (0.05, 0.62) -6 (0.04, 0.75) NA
24 hours 49/51 79 (9) 21 (9) 0 62 (9) 38 (10) 0 17 (<10-6, 1) -17 (<10-6, 1) NA
A population study of the effect of carbon black nanomaterial on erythrocyte shape. The average values of the portion of discocytes (D), echinocytes (E) and stomatocytes (S) are given after 1 hour, 3 hours and
24 hours of incubation with the carbon black nanomaterial (test sample) and with citrated and phosphate buffered saline (control sample). SD: standard deviation. p: statistical significance of the difference between











Figure 5 The effect of carbon black nanomaterial on population of platelets. The effect of carbon black (CB) nanomaterial on population of
platelets was observed by the scanning electron microscope. Washed platelets were incubated with citrated and phosphate-buffered saline
(PBS) for control (A, D, G), with PBS-suspended CB nanomaterial (B, E, H) and for comparison, with ZnO [11] (C, F, I) for 1, 3 and 24 hours,
respectively. After 1 and 3 hours the control and test samples contained disc-like platelets (A, B, D, E) characteristic for the resting state, while
there were some platelets exhibiting deviation from the disc-like shape and tubular protrusions (characteristic for activated platelets) found after
24 hours (E, F). For comparison, the effect of ZnO caused shape changes of some platelets after 3 hours (F) while after 24 hours all platelets
attained swollen globular shape with remnants of tubular protrusions, indicating their activation (G).
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tubular protrusions characteristic for activated platelets
after 24 hours (I).
Carbon black effect on giant unilamellar phospholipid
vesicles
Figure 6 shows the effect of CB nanomaterial on GUV
abundance and shape. Incubation of GUVs with CB nano-
material caused a considerable decrease in the number of
GUVs already after 20 minutes (Figure 6A). The remaining
GUVs in the test suspension exhibited higher eccentricity
than the control GUVs (Figure 6B).
Carbon black effect on parameters of blood cell
populations
Tables 2, 3, 4 show blood cell population parameters
(erythrocyte parameters: erythrocyte concentration
RBC, hematocrit HCT, red cell distribution width RDW
and hemoglobin distribution width HDW (Table 2),
platelet parameters: concentration of platelets PLT, pla-
teletcrit PCT, mean platelet volume MPV, platelet distri-
bution width PDW, mean platelet complement MPC
and mean platelet mass MPM (Table 3) and concentra-
tions of leukocyte populations: total leukocytes (WBC),
neutrophils, lymphocytes, monocytes, eosinophils andbasophils, (Table 4) of samples incubated with two dif-
ferent concentrations of CB nanomaterial (0.5 mg/mL
(A) and 1 mg/mL (B)), and control samples (incubated
with equal volume of PBS). We found no differences be-
tween average values of parameters in test samples and
in control samples with respect to number, mass and
volume of erythrocytes and platelets and the shapes of
their distributions (Tables 2 and 3). We found statisti-
cally significant difference in parameter MPC which
measures refractive index of platelets (Table 3) and in
the number of leukocytes; control samples had consid-
erably less leukocytes than the control sample (20% (A)
and 16% (B), respectively) (Table 4). Moreover, we found
differences in distribution of events within the flow cyt-
ometer scatter diagram regions that are in blood sam-
ples attributed to different types of leukocytes (Table 4).
The number of events within the eosinophils and baso-
phils region was increased while the number of events
within the monocyte region was decreased with respect
to the control sample (Table 4). These differences were
statistically significant and of sufficient statistical power
(the power was considered sufficient if larger than 0.8).
However, there were no differences between the re-
spective samples incubated with different concentra-
tions of nanomaterial (Table 4).
Figure 6 The effect of carbon black nanomaterial on giant unilamellar vesicles. Quantity of giant unilamellar vesicles (GUVs) incubated in
chambers with 0.3 M glucose solution (control) and suspension of CB nanomaterial (0.05 mg/mL in 0.3 M glucose solution). Samples of GUVs
were incubated with sugar solution for control and with carbon black (CB) nanomaterial suspended in sugar solution (0.05 mg/mL), for
20 minutes and 50 minutes, respectively. Each empty dot corresponds to a number of vesicles obtained in one sample, i.e. one replicate of each
tested group. One sample of a population consists of all vesicles captured in two individual video tracks at different places in a chamber. Based
on preliminary calculations, two such video tracks capture approximately 3% of the whole population of vesicles in the chamber. The red square
in the center of the box plot represents the mean value of (A) the number of GUVs or (B) GUVs’ eccentricity, the central line is the median value,
and the lower and upper lines of the box represent the 25th and 75th percentiles. The whiskers are set at two standard deviations from the
mean value. Addition of CB nanomaterial considerably diminished the number of GUVs in the sample while the remaining GUVs exhibited an
increased eccentricity of the contour (elongation).
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We considered the effect of CB nanomaterial on bio-
logical membranes. We found that CB nanomaterial ag-
glomerated in PBS and in platelet rich plasma (Figure 1).
Agglomerates of CB nanomaterial were found to interact
with human erythrocytes (Figures 2 and 3). Adhesion of
agglomerates did not change the local membrane curva-
ture (Figures 2 and 3). SEM micrographs indicate that
the surface of large CB nanomaterial agglomerates in
close contact with membrane can be relatively small and
discretized (Figure 3D, white arrow). If attached over a
large area to a CB nanomaterial agglomerate, erythro-
cytes may be damaged. Figure 3B shows remnants of a
cell attached to huge CB nanomaterial complex. Large
holes with bulby circular edge were formed in the
membrane of the cell shown in Figure 3B (white arrow)
causing the cell interior and exterior to exchange the
solutions, and a considerable deformation of the shape.
Similarly, a cell shown in Figure 2H was attached to
huge CB nanomaterial complex over a large area.
However, such events were rarely observed in the SEM
micrographs.
Yet the interaction between CB nanomaterial agglomer-
ates and the membrane was strong enough to mediate thebridging interaction between erythrocyte membranes
(Figure 2B, white arrow) and induce formation of
agglomerate-cell complexes already after an hour of incu-
bation with CB nanomaterial in PBS – diluted blood cell
suspensions (Figure 4). Similar structures were formed
also in blood plasma (Figure 1D2). Such formations may
present mechanical occlusions in the bloodstream.
Incubation of the erythrocyte suspension with CB
nanomaterial preserved the average number of intact
cells after 24 hours. In the control and in the test sample
we observed an increase of the portion of echinocytes
with respect to discocytes with time but this process was
less prominent in the test sample than in the control
sample (Table 1).
In contrast, we observed a deleterious effect of ag-
glomerated CB nanomaterial on GUVs. We found a con-
siderable decrease in the number of GUVs already after
20 minutes of incubation with CB nanomaterial. Al-
though the GUV artificial membrane presents a back-
bone of biological membranes and therefore shares
important similarities with the membrane of an erythro-
cyte or a more complex cell, the difference between
these systems may derive also from the properties of
other parts of the experimental system (the composition
Table 2 Erythrocyte parameters in blood samples incubated with carbon black nanomaterial
Parameter Sample 1 2 3 4 5 6 7 8 9 10 11 12 13 14 AVG STD p
RBC (1012 cells/L) A 3.27 3.72 3.65 3.27 4.75 3.89 3.38 3.26 2.92 2.98 3.6 2.82 4.46 3.67 3.55 0.55 0.42 (A-C)
B 3.51 3.56 3.5 3.41 4.46 3.84 3.39 3.44 3.35 2.5 3.95 3.23 3.51 0.46 0.27 (B-C)
C 3.26 3.54 3.2 3.22 4.54 3.95 3.46 3.26 3.38 3.14 3.68 3.27 4.34 3.3 3.40 0.41 0.80 (A-B)
HCT (%) A 0.28 0.32 0.30 0.28 0.40 0.34 0.31 0.28 0.26 0.26 0.32 0.24 0.37 0.31 0.31 0.04 0.96 (A-C)
B 0.30 0.31 0.29 0.29 0.38 0.33 0.31 0.29 0.30 0.22 0.36 0.28 0.3 0.04 0.89 (B-C)
C 0.28 0.31 0.27 0.27 0.39 0.34 0.32 0.27 0.30 0.27 0.33 0.28 0.36 0.28 0.3 0.04 0.76 (A-B)
RDW (%) A 12.8 13.5 13 15.3 12.4 12.9 13.5 13.6 12.5 12.3 13 12.6 12.5 12.6 13.04 0.78 0.88 (A-C)
B 12.7 13.5 13 15.4 12.4 12.8 13.4 13.6 12.8 12.4 12.9 12.6 13.13 0.82 0.90 (B-C)
C 12.7 13.7 12.9 15.3 12.5 12.8 13.7 13.6 12.6 12.5 12.9 12.8 12.5 12.6 13.1 0.77 0.98 (A-B)
HDW (g/L) A 24.5 22.5 27.1 26.3 24.6 24.0 22.6 25.7 27.2 24.1 23.4 22.7 25.9 25.9 24.8 1.62 0.95 (A-C)
B 24.3 22.5 27.1 26.1 24.4 22.1 22.1 26.2 27.3 24.6 23.2 22.7 22.9 6.20 0.36 (B-C)
C 24.6 22.7 26.8 26.2 24.7 23.9 22.3 26.2 27.5 24.3 23.5 22.6 25.9 25.9 24.8 1.66 0.37 (A-B)
Erythrocyte parameters - (Erythrocyte (RBC), Hematocrit (HCT), RBC distribution width (RDW) and hemoglobin distribution width (HDW)) in blood samples incu-
bated with two different CB nanomaterial concentrations (A – 0.5 mg/mL, B - 1 mg/mL), and control suspension incubated with PBS (C). Average value (AVG),
standard deviation (STD) and statistical significance of the difference between the test and the control samples (A-C and B-C, respectively) and between the two
test samples (A-B), given by the respective probability (p).
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tact of the sample and the laboratory material).
When GUVs are formed in the electroformation
process, they are connected by a network of nanotubules
[27]. This network is torn when GUVs are rinsed out of
the electroformation chamber, but its remnants stayTable 3 Platelet parameters in blood samples incubated with
Parameter Sample 1 2 3 4 5 6 7 8
PLT (109 cells/L) A 106 71 91 62 56 69 169 -
B 61 56 99 80 49 104 176 56
C 117 82 129 86 56 117 182 10
PCT (%) A 0.1 0.07 0.09 0.07 0.05 0.07 0.16 0.0
B 0.06 0.06 0.1 0.08 0.05 0.1 0.17 0.0
C 0.11 0.08 0.13 0.08 0.05 0.11 0.16 0.0
MPV (fL) A 9.5 10.5 9.9 10.5 9.2 9.7 9.4 9.2
B 10 10.5 10.2 9.9 9.3 9.6 9.6 8.8
C 9.5 10.3 10.1 9.7 9 9.5 8.8 8.7
PDW (%) A 56 63.8 57.6 65.4 72.2 61.3 62.1 67
B 61.5 61.0 59.7 56.8 63.2 61.8 61.8 54
C 54.6 62.3 55.4 54 60.2 58.1 58.3 59
MPC (g/L) A 215 211 216 209 223 222 228 20
B 189 206 219 215 218 236 218 21
C 214 225 222 232 226 239 232 23
MPM (pg) A 1.89 1.99 1.95 0.96 1.81 1.97 1.97 1.7
B 1.72 1.96 2.01 1.94 1.84 2.06 1.91 1.7
C 1.88 2.09 2.04 2.07 1.86 2.1 1.89 1.8
Platelet parameters (Platelet count (PLT), plateletcrit (PCT), platelet distribution widt
platelet component (MPC)) in blood samples incubated with two different carbon b
suspension incubated with citrated and phosphate-buffered saline (C). Average valu
between the test and the control samples (A-C and B-C, respectively) and between
significant differences have also been evaluated for statistical power at α = 0.05 (P).attached to the GUVs [28]. Under an optical microscope
fresh GUVs appear spherical while the attached nanotu-
bules cannot be observed due to their thinness. If a
spontaneous process exists within the observation cham-
ber which removes the lipid molecules from the outer
layer, the average mean curvature of the membranecarbon black nanomaterial
9 10 11 12 13 14 AVG STD p P
114 146 114 109 38 37 89.4 39.0 0.16 (A-C)
123 184 92 119 99.9 44.9 0.21 (B-C)
4 121 209 141 129 49 59 113 45.9 0.91 (A-B)
6 0.11 0.13 0.1 0.1 0.04 0.03 0.08 0.04 0.21 (A-C)
5 0.12 0.16 0.08 0.11 0.10 0.04 0.31 (B-C)
9 0.11 0.17 0.12 0.12 0.05 0.05 0.10 0.04 0.87 (A-B)
9.6 8.6 9 8.9 9.4 8.3 9.41 0.63 0.62 (A-C)
9.6 8.4 8.7 9.4 9.5 0.63 0.39 (B-C)
9 8.4 8.8 9.6 9.7 9 9.29 0.56 1.00 (A-B)
.7 59.1 54 61.9 53.8 51.6 47.7 59.6 6.67 0.15 (A-C)
.5 56.8 55.4 47.2 60 58.3 4.49 0.31 (B-C)
.7 52.9 52.4 60 50.9 56.3 57.8 56.6 3.39 0.17 (A-B)
9 215 219 219 229 206 174 214 13.4 0.02 (A-C) 0.88
2 220 220 209 229 216 11.7 0.00 (B-C) 0.84
3 230 230 229 229 219 193 225 11.2 0.61 (A-B)
4 1.88 2.74 1.79 1.89 1.78 1.38 1.84 0.38 0.45 (A-C)
3 1.92 1.71 1.72 1.89 1.87 0.12 0.10 (B-C)
7 1.92 1.77 1.86 2.03 1.92 1.6 1.92 0.14 0.90 (A-B)
h (PDW), mean platelet volume (MPV), mean platelet mass (MPM) and mean
lack nanomaterial concentrations (A – 0.5 mg/mL, B – 1 mg/mL), and control
e (AVG), standard deviation (STD) and statistical significance of the difference
the two test samples (A-B), given by the respective probability (p). Statistically
Table 4 Leukocyte parameters in blood samples incubated with carbon black nanomaterial
Parameter Sample 1 2 3 4 5 6 7 8 9 10 11 12 13 14 AVG STD p P
WBC (109 cells/L) A 8.51 6.81 8.45 6.3 6.13 8.97 6.92 8.1 8.83 7.05 6.91 6.12 4.74 4.71 7.04 1.39 0.04 (A-B) 0.81
B 9.04 5.97 8.12 5.78 6.33 8.28 7.12 7.29 8.94 8.55 8.3 7.46 7.60 1.13 0.00 (B-C) 1
C 7.82 5.36 7.1 4.65 4.24 6.56 6.2 5.98 7.59 6.04 6.04 6.72 4.78 4.57 5.98 1.14 0.70 (A-B)
Neutrophil region (109 cells/L) A 3.04 4.82 5.81 3.18 4.59 3.99 4.62 3.05 2.57 3.97 3.53 3.24 3.21 2.37 3.71 0.97 0.25 (A-B)
B 4.05 5.58 5.72 4.15 4.19 3.86 4.35 3.46 2.5 3.79 3.89 3.08 4.05 0.91 0.04 (B-C) 0.86
C 3.79 4.12 5.29 2.93 3.74 3.68 3.72 2.29 1.98 3.33 3.22 2.89 3.05 2.29 3.31 0.86 0.37 (A-B)
Lymphocyte region (109 cells/L) A 2.14 1.39 1.71 2.84 1.74 2.11 2.35 1.97 2.7 3.53 3.11 2.46 1.01 1.82 2.21 0.68 0.58 (A-B)
B 2.17 1.62 1.83 3.17 1.66 2.05 2.2 1.75 2.45 3.33 2.91 2.15 2.27 0.58 0.39 (B-C)
C 2.15 1.56 1.71 2.56 1.61 1.97 2.12 1.56 2.37 3.17 3.16 2.04 1.19 1.86 2.07 0.58 0.78 (A-B)
Monocyte region (109 cells/L) A 0.14 0.19 0.23 0.27 0.22 0.23 0.24 0.24 0.08 0.2 0.18 0.15 0.25 0.15 0.20 0.05 0.00 (A-B) 1
B 0.18 0.17 0.23 0.33 0.16 0.17 0.2 0.34 0.11 0.16 0.21 0.16 0.20 0.07 0.00 (B-C) 1
C 0.4 0.24 0.36 0.43 0.31 0.39 0.36 0.3 0.22 0.3 0.36 0.3 0.34 0.18 0.32 0.07 0.87 (A-B)
Eosinophil region (109 cells/L) A 0.69 0.38 0.95 0.76 1.41 0.44 1.61 0.72 0.8 0.63 1.6 0.9 0.2 0.3 0.81 0.45 0.00 (A-B) 1
B 0.91 0.85 1.02 0.82 1.06 0.92 1.29 0.66 0.58 0.64 1.88 0.5 0.93 0.37 0.00 (B-C) 1
C 0.35 0.08 0.19 0.09 0.3 0.12 0.31 0.07 0.06 0.27 1.04 0.09 0.17 0.19 0.24 0.25 0.49 (A-B)
Basophil region (109 cells/L) A 0.1 0.14 0.14 0.28 0.13 0.14 0.14 0.15 0.15 0.1 0.1 0.06 0.06 0.07 0.13 0.06 0.00 (A-B) 1
B 0.16 0.06 0.15 0.07 0.2 0.12 0.23 0.12 0.14 0.2 0.15 0.08 0.14 0.05 0.00 (B-C) 1
C 0.2 0.03 0.02 0.03 0.03 0.04 0.06 0.02 0.03 0.04 0.04 0.03 0.03 0.04 0.05 0.05 0.51 (A-B)
Leukocyte parameters (Leukocyte count (WBC) and counts within Neutrophil region, Lymphocyte region, Monocyte region, Eosionphil region and Basophil region) in blood samples incubated with two different carbon
black nanomaterial concentrations (A – 0.5 mg/mL, B – 1 mg/mL), and control suspension incubated with citrated and phosphate-buffered saline (C). Average value (AVG), standard deviation (STD) and statistical
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possible the GUV adjusts its shape by integration of the
nanotubule(s). Concomitantly, the globular part of the
GUV becomes flaccid and its thermal shape fluctuations
become visible [28] while the eccentricity of GUVs in-
creases when the protrusions are integrated in the
mother vesicle. It is important at which stage of this
process the test substance (CB nanomaterial) was added
to GUVs. Added CB nanomaterial interacts with solutes,
and with surfaces of the observation chamber which af-
fects the osmolarity of the suspension. Water migrates
through the phospholipid membrane [29] to equalize its
chemical potential. If inserted in hypotonic medium, this
mechanism causes GUVs to swell while for large enough
differences in chemical potential they burst [30]. Experi-
ments with GUVs were performed immediately after the
electroformation when the mother vesicle was almost
spherical with hindered possibilities to adjust its shape.
As the membrane poorly tolerates stretching, the vesi-
cles which were almost spherical, bursted. This mechan-
ism provides a possible explanation for the decrease of
the number of GUVs in the first 20 minutes of observation
(Figure 6). Measured 50 minutes after the addition of the
CB nanomaterial, the number of GUVs remained more or
less unchanged with respect to the measurements at
20 minutes. Also, the remaining GUVs in the test sample
exhibited larger average eccentricity than the GUVs in the
control sample. In agreement with the proposed mechan-
ism we interpret that the vesicles which have prior to
addition of CB nanomaterial integrated enough mem-
brane from the remnants of the nanotubular network
were flaccid enough and therefore able to adjust their
shape and resist the osmotic shock. Similar osmotic effects
took place also in erythrocyte suspension, however, eryth-
rocytes have a relatively low relative volume (in discocytes
which prevailed in the samples considered this ratio is
below 0.7), so the cells were able to adjust their shape in
attaining the osmotic equilibrium. As cells were far from
the limiting spherical shapes they did not burst, instead,
they adjusted their shape by minimizing the free energy of
the membrane with underlying membrane skeleton [31]
according to the new conditions. Bursting of GUVs in the
experiment (Figure 6) therefore likely reflects the in vitro
conditions.
Echinocytosis in in vitro conditions was observed in the
control and in the test sample. The possible mechanisms
include interaction of solutes with glass surface of the ob-
servation chamber [32], change of the difference between
the outer and the inner membrane layer areas due to
change in composition or shape of the membrane constitu-
ent molecules [33-36], change in the composition of the
inner and the outer solution [37] and ATP depletion [38].
CB nanomaterial may interfere with these mechanisms. As
the zeta potential is negative, the nanoparticles and theiragglomerates attract positively charged molecules in the so-
lution and thereby cause changes of the bulk concentration
of solutes, with consequent changes in the Donnan equilib-
rium including pH and therefrom induced transformations
of membrane protein conformation [39]. Also, CB nanoma-
terial may interact with the glass surfaces of the observation
chamber and indirectly affect the glass – induced mechan-
ism responsible for echinocytosis in the control sample.
However, the effect of CB nanomaterial in our case sup-
pressed the echincytogenic effect observed in the control
sample (Table 1).
We found singular ghosts in the samples treated with
CB nanomaterial (Figure 3B) but the membrane of the
blood cells did not appear locally deformed due to the
presence of CB nanomaterial (Figures 2 and 3). CB
nanomaterial also did not cause dramatic changes in
platelet shape (Figure 5). The treated and the control
samples contained mostly resting platelets while the
signs of the platelet activation after 24 hours of incuba-
tion with CB nanomaterial (roundness of shape, the
presence of the tubular protrusions) were observed also
in the control sample and were therefore not ascribed to
the effect of CB nanomaterial. Figure 5 for comparison
presents also platelets that were incubated with agglom-
erated ZnO where it can be seen that after 24 hours the
platelets were considerably activated, but as previously
found [11] this effect can be observed already 3 hours
after the addition of ZnO nanoparticles to blood cells.
Further, no differences between CB-treated samples and
control samples with respect to number, mass and volume
of platelets and shapes of their distributions were found.
This indicates lack of evidence for platelet activation which
is in agreement with our other results. However, we found
statistically significant differences in parameter MPC which
measures refractive index of platelets. MPC was suggested
as a potential measure of the activation of platelets, however
the results are not yet decisive [40]. A change in refractive
index of platelets due to incubation with CB nanomaterial
(Table 2) could in our experiments be a consequence of ad-
sorption of nanoparticles to the cell surface, (Figure 2).
It was found that the number of leukocytes was statis-
tically significantly increased in samples incubated with
CB nanomaterial. Peroxidase reaction staining showed
an increase of the number of stained particles that are
in blood samples ascribed to eosinophils. We suggest
that higher number of leukocytes in CB-treated samples
could be a consequence of detecting CB aggregates by
the cytometer in the frame within the scatter diagram
pertaining to leukocytes and of a decreased adsorption
of leukocytes to epruvette walls in samples treated with
CB nanomaterial. Higher number of peroxidase stained
cells could be due to adsorption of CB nanomaterial
to the cell surface, thereby influencing the position of
events in the cytometer scatter diagram.
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24 hours since this was the interval in which interaction
of nanomaterial with membranes took place in our
previous experiments with TiO2 and ZnO [11]. We used
the concentration of nanomaterial of the same order
that showed an effect in previous work. In analysis of
standard blood parameters we used two different con-
centrations of CB nanomaterial, however, we observed
no difference between samples incubated with different
concentrations of nanomaterial (Table 2).
In this work we have focused on the effect of CB nano-
material on biological membranes as revealed by the
change of the erythrocyte, platelet and phospholipid
vesicle shape. Activation of platelets can be assessed also
by other methods, therefore, further studies should be
performed taking into account different aspects of blood
coagulation.
Our results do not indicate a CB nanomaterial – in-
duced risk for thromboembolic events due to an increased
activation of platelets. However, the risk for occlusion of
small vessels is indicated due to the formation of rather
large agglomerates which may present mechanical occlu-
sions in the vessels. Adhesion of blood cells to these com-
plexes additionally aggravates the situation. Moreover, by
mediating the attractive interaction between membranes,
CB nanomaterial accumulated in the erythrocyte dimple
can stabilize the shape of the cell that is unfavorable for
flow through capillaries. Larger complexes of agglomer-
ated CB nanoparticles present a risk for the occlusion of
the vessels even with no cells attached.
The observed effects of interaction of nanomaterial
with biological membranes on their biophysical proper-
ties present only one viewpoint on the effect of nanoma-
terial on cells. It was observed that PEGylated gold
nanoparticles considerably affected function of erythro-
cytes (decrease of deformability, oxygen delivering abil-
ity, CD47 and ATP content, aggregation of band-3),
although they did not cause haemolysis [41]. Moreover,
these effects can in vivo last for weeks due to biocom-
patibility of nanoparticles [41]. It was suggested that de-
creased deformability of erythrocytes could be a
consequence of adsorption of gold nanoparticles on the
erythrocyte membrane [41]. As we have also observed
adsorption of CB (Figure 2) as well as of TiO2 and ZnO
nanomaterial [11] on the erythrocyte membrane, similar
long lasting effects of CB nanomaterial would also be
probable in vivo. Activation of human platelets was
induced by nanodiamonds [42], in vivo effect on im-
mune system was induced by uptake of carbon ultrafine
particles [43], drug carrier nanoparticles dendrimeres were
found to induce procoagulant activity of leukocytes [44] and
genotoxic effects of TiO2 were reported in leukocytes [45].
On the other hand, carbon nanotubes did not induce acute
immune response [46]. To better understand underlyingmechanisms, further studies considering different view-
points and different types of nanomaterial are therefore
indicated.
Blood cells are a convenient system for the study of
the effect of different substances on cells and biological
membranes. Monocytes were found an appropriate sys-
tem for testing the pyrogeneicity of compounds alterna-
tive to rabbit immune response [47-49]. Erythrocytes,
platelets and GUVs can also reveal information on the
relevant effects. It is however necessary to continue im-
proving the methods for quantification of these effects
and expanding the possibilities of the use of blood cells.
Analysis of the sample in the observation chamber in-
volves taking images of the sample at different locations.
When comparing the images it can be clearly seen that the
sample is not completely homogeneous with respect to the
number of cells and cell shapes. Statistical analysis of the
representative images of the sample should therefore be per-
formed. We have previously developed a computer aided
method to assess an ensemble of representative images and
analyzed the effect of different substances on GUVs [50,51].
In this work a statistical approach is used also to compare
the concentration and the shape of erythrocytes. We have
distinguished between three different types of erythrocyte
shapes (discocyte, echinocyte and stomatocyte). As besides
the errors of this method, the source of the fluctuations in
the average values are also systemic errors in preparing the
sample, we presented the results in terms of the portions of
cells of a certain type of the shape. A choice of relevant pa-
rameters and an iterative approach involving the construc-
tion of an ensemble of images representative for the system,
calculating the average values and statistical significance of
the differences and checking whether the power of the en-
semble is large enough will lead to the optimization of the
method with respect to the time used for analysis.
The analysis of the potentially prothrombogenic effect
of exogenously added substance could be complemented
by considering also the extracellular vesicles isolated from
blood samples [13,52]. Currently, the most widely used
markers for assessment of extracellular vesicles are the
antibodies. However, development of ethically superior
materials (aptameres) that are produced in vitro [53], and
the corresponding technologically advanced methods [54]
should be considered.
It was reported that various types of nanoparticles and in
particular CB, can directly oxidize molecules by surface-
mediating reactions and leakage of transition metals and
redox-active substances, and thus damage the membranes
[3]. CB nanomaterial was also observed to induce apoptosis
in HUVECs [55] and in bronchial epithelial cells [56] which
was interpreted by leakage of the enzymes due to (mito-
chondrial) membrane injury [56]. Biochemical approaches
also indicate the importance of the integrity, composition
and properties of the membrane in vital cell processes and
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properties and relevant interactions are crucial in nanotoxi-
cology studies.
Analysis of the shape and population characteristics of
erythrocytes and GUVs provides a quantitative method
suitable for the study of the effect of added substances
on biological membranes and should be considered in
the future paradigms of research and testing.
Conclusions
Carbon black nanomaterial suspended in citrated and phos-
phate buffered saline interacted with erythrocyte membrane
but in 24 hours the direct interactions did not cause ob-
servable changes in local membrane shape or in global
erythrocyte shape. Also we observed no changes in shape
of platelets due to incubation of platelet rich plasma with
the nanomaterial within 24 hour observation and in popu-
lation parameters that consider concentration, volume and
distribution shape. The carbon black nanomaterial however
formed large agglomerates in sugar solution, in citrated and
phosphate buffered saline and in blood plasma. Indirect ef-
fects on the artificial membranes were interpreted by
changes in osmolarity induced by addition of carbon black
nanomaterial to the giant phospholipid vesicle suspensions.
Blood cells and giant phospholipid vesicles are appropriate





Phosphocholine (POPC) and cholesterol were purchased
from Avanti Polar Lipids, Inc. (Alabaster, Al, USA).
Sucrose and glucose were purchased from Sigma–Aldrich
(Steinheim, Germany). Stock solutions (1 mg/mL) of both
POPC and cholesterol were prepared by dissolving the
lipid in a mixture of CHCl3 and MeOH (2:1, v/v). Sucrose,
glucose, paraformaldehyde, CHCl3 and MeOH were pur-
chased from Sigma–Aldrich (Steinheim, Germany), NaCl,
NaH2PO4⋅2H2O, Na2HPO4⋅2H2O and Triton X 100 sur-
factant (OmniPur) from Merck KGaA (Darmstadt,
Germany) and KCl and KH2PO4 from Kemika (Zagreb,
Croatia). Citrated and phosphate buffered saline (PBS):
137 mM NaCl, 2.7 mM KCl, 7.8 mM Na2HPO4⋅2H2O,
1.5 mM KH2PO4, 10.9 mM Na3C6H5O7, pH 7.4) was pre-
pared with ultrapure distilled H2O and filtered before use
through 0.22 μm pore filters. Glutaraldehyde and osmium
tetroxide (OsO4) were purchased from SPI Supplies (West
Chester, PA USA).
Carbon black nanomaterial
CB nanopowder was from PlasmaChem GmbH (Berlin,
Germany). The average size of primary particles was13 nm. Stock suspensions of CB nanomaterial were pre-
pared in PBS at 5 mg/ml.Characterization and imaging of carbon black
nanomaterial suspensions
Characterization of CB nanomaterial (primary charac-
teristics of CB nanomaterial) and nanoparticle suspen-
sions (secondary characteristics of CB nanomaterial)
were assessed by SEM and TEM electron microscopy,
by DLS and by zeta potential measurements. For TEM,
water suspension of nanoparticles was applied on a
copper-grid-supported transparent carbon foil at room
temperature. TEM imaging of nanomaterial was per-
formed using a JEOL 2100 transmission electron micro-
scope (Tokyo, Japan) operated at 200 kV. SEM imaging of
nanomaterial in PBS was performed using LEO Gemini
1530 (LEO, Oberkochen, Germany) scanning electron
microscope.
Dispersed CB nanomaterial dissolved in PBS was
inspected by DLS using 3D DLS-SLS spectrometer (LS
Instruments, Fribourg, Switzerland). Zeta potential of CB
nanomaterial in PBS was measured at the pH value of
the suspension using ZetaPals (Brookhaven Instruments
Corporation, Holtsville, NY, USA).Blood sampling
For SEM imaging blood was collected from two authors
(female and male, average age 40 years) and a volunteer
(female, 30 years) with no record of the disease into
2.7 mL tubes containing 270 μL trisodium citrate at a
concentration 0.109 mol/L. Blood was collected by vein
puncture with free flow into tubes (BD Vacutainers,
Becton Dickinson, CA) by using a 21-gauge needle
(length 70 mm, inner radius 0.4 mm) (Microlance,
Becton Dickinson, NJ, USA). Sampling was performed
according to the Declaration of Helsinki and a written
consent to take blood was given by the donors. The
study was approved by the National Ethics Committee,
No 117/02/10. No adverse effects on donors’ health due
to sampling were observed.
For direct observation under the optical microscope, a
drop of blood was taken from an author (female, 54 years)
with a pipette from a small incision on a fingertip. Blood
was inserted into an Eppendorf tube previously filled with
1 mL of PBS and gently mixed by turning the sample up-
side down.
For the study of population of blood cells, 2.3 mL of
blood was collected from 14 volunteers with no record of
disease (13 female and 1 male, average age 22 years) into
evacuated tubes (BD Vacutainers, Becton Dickinson, CA)
containing 270 μL trisodium citrate at a concentration
0.109 mol/L. Blood was collected by vein puncture by using
a 21-gauge needle (length 70 mm, inner radius 0.4 mm)
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nated 3 tubes of blood.
Preparation of blood cells for electron microscopy
Blood was processed within 1 hour from sampling. Blood
was centrifuged in a Centric 400R centrifuge (Domel d.o.o.,
Železniki, Slovenia) at 150 g and 37°C for 10 minutes to sep-
arate erythrocytes from platelet rich plasma. Erythrocytes
were repeatedly washed with PBS by centrifugation at
1550 g and 37°C for 10 minutes. Washed erythrocytes or
platelet rich plasma were aliquoted into equal parts (50 μL
in case of erythrocytes and 200 μL in case of platelet rich
plasma). CB nanomaterial suspended in PBS (or PBS alone
for control) was added to aliquots in v/v ratio of 2:1 in case
of erythrocytes and 3:1 in case of platelet rich plasma, 3 and
2 units corresponding to erythrocytes and platelet rich
plasma, respectively. After incubation the samples were
fixed in 0.1% glutaraldehyde, incubated for another hour at
room temperature and centrifuged at 1550 g and 37°C for
10 minutes. Supernatant was exchanged for PBS samples
were vortexed, centrifuged at 1550 g and 37°C for
10 minutes and fixed in 2% glutaraldehyde for an hour.
Phase contrast microscopy of erythrocytes
5 μL of erythrocyte suspension was placed into observation
chamber composed of two cover glasses which were glued
together with nail polish. Samples were observed under
Olympus GWB BH-2 (Olympus Corporation, Tokyo, Japan)
microscope with phase contrast optics at objective magnifi-
cation 400×. Images were taken with Canon EOS 450D
digital camera (Canon Inc., Tokyo, Japan).
Scanning electron microscopy of blood cells
Fixed samples were washed by exchanging supernatant with
PBS and incubated for 20 minutes at room temperature.
This procedure was repeated 4 times while the last incuba-
tion was performed over night at 8°C. Samples were then
post-fixed for 60 minutes at 22°C in 1% OsO4 dissolved in
0.9% NaCl, dehydrated in a graded series of acetone/water
(50%–100%, v/v), critical-point dried, gold-sputtered, and
examined using a LEO Gemini 1530 (LEO, Oberkochen,
Germany) scanning electron microscope.
Carbon black nanomaterial effect on erythrocyte shape in
populations of erythrocytes
PBS-diluted blood samples incubated with the test or con-
trol solution were observed under the Leitz Aristoplan
(Leitz, Wetzlar, Germany) optical microscope equipped by
the Watec (Model: 902DM3S), Watec Inc., New York,
USA, camera and Pinnacle Studio HD, Version 15.0.0.7593
frame graber and software, Avid Technology Inc., USA.
Final concentration of CB nanomaterial in samples was
0.5 mg/mL. The samples were observed after 1, 3 and
24 hours, in order to compare the effect with previouslyconsidered effect of TiO2 and ZnO nanoparticles [11].
The sample was further diluted to obtain a required dens-
ity of blood cells for observation. The required density
rendered a monolayer of relatively closely packed cells in
an observation frame under the microscope. An observa-
tion chamber 1.5 × 1 cm2 was created on the glass by
using silicon grease. 40 μL of the test suspension was
placed in the observation chamber and closed by the cover
glass. Care was taken not to leave voids in the grease
boundary in order to prevent evaporation of liquid from
the observation chamber. For quantitative analysis of the
effect of CB nanomaterial on blood cell membranes we
randomly imaged at least 50 frames over the sample. We
avoided regions close to the silicon grease. Two independ-
ent experiments were performed.
Image analysis of blood cell populations
For each sample we created an ensemble of pictures
from which we omitted pictures of invalid quality. We
counted the number of discocytes, echinocytes and sto-
matocytes in each picture. It was assumed that each pic-
ture was representative for the sample and that the
number of cells of each type fluctuated around the cor-
responding average value. The average values of the per-
cent of discocytes, echinocytes and stomatocytes were
calculated for each sample. Altogether 10712 cells were
included in the final analysis.
Electroformation of giant unilamellar phospholipid
vesicles
The electroformation of GUVs [49] was performed at room
temperature. In brief, 40 μL of the lipid mixture of POPC
(80%, v/v) and cholesterol (20%, v/v), both dissolved in 2:1
chloroform/methanol mixture, was spread over two plat-
inum electrodes and the solvent was allowed to evaporate
in low vacuum for two hours. The electrodes were then
placed into the electroformation chamber (2 mL Eppendorf
cup), filled with 2 mL of 0.3 M sucrose solution. An alter-
nating electric field was applied as described in [57]. After
the electroformation, 600 μL of 0.3 M sucrose solution con-
taining GUVs was added to 1 ml of 0.3 M glucose solution.
Experiments with giant unilamellar phospholipid vesicles
and carbon black nanomaterial
Immediately after the electroformation, the suspension of
GUVs in sucrose/glucose solution was mixed by turning
the Eppendorf cup upside down (five times). The suspen-
sion was diluted (300 μL of 0.3 M glucose solution was
added to 100 μl of original vesicle solution) in order to ob-
tain the desired concentration of GUVs, which was found
convenient according to our preliminary experiments.
Subsequently, the diluted suspension was aliquoted into 2
vials (80 μL in each vial). Two parallels of test suspension
of CB nanomaterial (0.05 mg/mL in 0.3 M glucose
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cose solution) were added to GUV suspensions in volume
ratio 9:1 (GUVs: test suspension) to reach the final concen-
tration of nanomaterial 10 μg/mL. Vials were turned upside
down five times to mix the test suspension with GUV
suspension. Thus obtained samples (70 μL each) were separ-
ately transferred into four CoverWellTM Perfusion cham-
bers PC4L-0.5 (Grace Bio-Labs Sigma-Aldrich, Steinheim,
Germany).
The observation chambers with samples were mounted
to the inverted phase contrast light microscope (Nikon
Eclipse TE2000-S, Tokyo, Japan). After pre-defined dura-
tions of incubation (20 and 50 minutes), GUV populations
in each chamber were recorded by a Sony CCD video
camera module, model: XC-77 CE (Minato, Japan). These
recordings consisted of two video sequences each approxi-
mately 2 minutes long. During the recording, the object
glass was moved to capture images of thousands of GUVs.
With the use of image processing algorithms, the video se-
quences were transformed into large mosaics [58] where
each mosaic contained all vesicles acquired within the
sample. GUVs in mosaics were segmented by using a
computer-aided approach [58].
A sample of GUVs was incubated with sugar solution
for control and another sample was incubated with CB
nanomaterial dissolved in sugar solution (0.05 mg/mL).
The vesicles were imaged after 20 minutes and after
50 minutes.
The mosaics were separated into images (micrographs)
with the size of a single field of view with the microscope at
400× magnification. Using the GUVs’ locations inside the
mosaics, all vesicles were associated with the appropriate
micrograph allowing us to extract information on vesicle
density throughout the micrographs composing the mosaic.
Numbers of GUVs in the micrograph were averaged over all
micrographs within the test and control samples.
Vesicle shapes were characterized by their deviations
from sphere. The nonspherical contours were approxi-
mated by fitting with an ellipse with smaller semiaxis b and
larger semiaxis a. The eccentricity ε = (1 - b2/a2) 1/2 was
assigned to each vesicle in the mosaic and the average value
for the sample was calculated.
Analysis of blood cell populations with respect to
concentration, volume and distribution
Each subject donated 3 samples of blood to create 3 popula-
tions of samples. Population A was incubated with 200 μl
PBS-dissolved CB nanomaterial with final concentration
0.5 mg/mL, population B was incubated with equal volume
of PBS-dissolved CB nanomaterial with final concentration
1 mg/mL, population C was incubated with equal volume of
PBS. Samples were incubated for one hour during which
they were continuously slowly turned upside down at room
temperature. After one hour the samples were left in uprightposition for another hour to allow sedimentation of nano-
material to the bottom of the tubes. Upper milliliter of the
samples was pipetted into plastic tubes. After additional
10 minutes, the samples were examined for presence of CB
agglomerates. 40 μl of sample was taken with the pipette
from the bottom of the tube and placed into an observation
chamber created between two cover glasses by silicon
grease. No CB agglomerates were observed under the op-
tical microscope Leitz Aristoplan (Leitz, Wetzlar, Germany)
equipped by the Watec (Model: 902DM3S), Watec Inc.,
New York, USA, camera and Pinnacle Studio HD, Version
15.0.0.7593 frame graber and software, Avid Technology
Inc., USA. Blood cell populations were assesed by the
ADVIA flow cytometer for erythrocyte parameters: erythro-
cyte concentration RBC, hematocrit HCT, red cell distribu-
tion width RDW and hemoglobin distribution width HDW,
platelet parameters: concentration of platelets PLT, platelet-
crit PCT, mean platelet volume MPV, platelet distribution
width PDW, mean platelet complement MPC and mean
platelet mass MPM, and leukocyte concentration (WBC).
Statistical analysis
Methods of descriptive statistics were used to compare
the test samples and the respective control samples. We
used two-sided pooled t-test with equal variance. Prob-
ability of the t-test below 0.05 was considered statisti-
cally significant. The software used for statistical analysis
was from R Development Core Team: R: A language and
environment for statistical computing [59]. The statis-
tical significance of the t- test was given by the probabil-
ity of the type I or type II error (i.e. by α or β). Power
analysis was performed in order to validate the size of
samples. Power larger than 0.8 at α = 0.05 indicated the
sample of a proper size. For calculation, we used Micro-
soft Excel software (Microsoft® Office Excel® 2007 SP3)
and Power & Sample Size Calculator.
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